Below are links to view the quarterly newsletter Targeting Trends. If you would like to be added to the mailing list, please complete the information on our contact page.
Newsletter Highlights
- Surf Contest (page 2)
- Teaser Winners (page 2)
- 2005 SfN Poster Award Winner (page 6)
- Streptavidin-ZAP (page 7)
[fivecol_one]Page 1 
Page 2 
Page 3 
Page 4 
Page 5 
Page 6 
Page 7 
Page 8 
[/fivecol_one][fivecol_four_last]
The Biologically Active Cholecystokinin (26-33) peptide, [Tyr2-SO3]CCK-8, Retains High Affinity for CCK2 Receptors after Covalent Conjugation to Saporin – read article (continued on page 6)
Josephine Lai, Wenjun Zhang, Hamid Badghisi, Victor J. Hruby and Frank Porreca,
Departments of Pharmacology and Chemistry, The University of Arizona, Tucson, AZ 85724.Product information related to cover article: CCK-SAP (Cat. #IT-31)
Tony Mezzadri Surf Contest
Targeting Teaser Winners
Recent Scientific References – read online
Upcoming Events
- In a recent experiment using a saporin-antibody conjugate injected systemically we saw changes in dendritic cells that could be consistent with an LPS effect. Does ATS test for LPS and has this ever been identified as a problem before?
This brilliant artistic expression is a creation by Dr. Roger Guillemin (see brief bio on page 2). The title of this piece is Hamadryad.
The Biologically Active Cholecystokinin (26-33) peptide,[Tyr2-SO3]CCK-8, Retains High Affinity for CCK2 Receptors after Covalent Conjugation to Saporin – read article
(continued from page 1)
17th Annual Spring Brain Conference (www.springbrainconferences.org)
2005 Society for Neuroscience Poster Award Winner (read abstract featuring IT-12 Dermorphin-SAP, IT-26 CCK-SAP)
Targeting Tools: Featured Products
- Streptavidin-ZAP (Cat. #IT-27) – read article
- Biotinylation Service (Details)
Targeting Teaser (Jumble)
[/fivecol_four_last]